Controversies in the Surgical Management of Differentiated Thyroid Carcinoma

International Surgery

Volumn 81, Issue 2, 1996, Pages 163-167

  Noguchi, M ^a   Katev, N ^a   Miyazaki, I ^a  

^a KANAZAWA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Lymph nodes neoplasms; Thyroid cancer; Thyroidectomy

Indexed keywords

ARTICLE; CANCER SURGERY; HIGH RISK PATIENT; HUMAN; LYMPH NODE METASTASIS; SURGICAL TECHNIQUE; THYROID CARCINOMA; THYROIDECTOMY;

ADENOCARCINOMA, FOLLICULAR; CARCINOMA, PAPILLARY; HUMANS; IODINE RADIOISOTOPES; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 0029988282     PISSN: 00208868     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (91)

1. Schelfhout LJ DM, Creutzberg CL, Hamming JF et al. Multivariate analysis of survival in differentiated thyroid cancer: the prognostic significance of the age factor. Eur J Cancer Clin Oncol 1988;24:331-337.
2. Byar DP, Green SB, Dor P et al. A prognostic index for thyroid carcinoma. A study of the EORTC thyroid cancer cooperative group. Eur J Cancer 1979;15:1033-1041.
3. Bacourt F, Asselain B, Savoie JC et al. Multivariate study of prognostic factors in differentiated thyroid carcinoma and a re-evaluation of the importance of age. Br J Surg 1986;73:274-277.
4. Kerr KJ, Burt AD, Boyle P et al. Prognostic factors in thyroid tumors. Br J Cancer 1986;54:475-482.
5. Tennvall J, Biorklund A, Moller T et al. Is the EORTC prognostic index of thyroid cancer valid in differentiated thyroid carcinoma? Cancer 1986;57:1405-1414.
6. Hannequin P, Liehn JC, Delisle MJ. Multifactorial analysis of survival in thyroid cancer. Cancer 1986;58:1749-1755.
7. Tubiana M, Schlumberger M, Rougier P et al. Long-term results and prognostic factors in patients with differentiated thyroid carcinoma. Cancer 1985;55:794-804.
8. Noguchi M, Mizukami Y, Michigishi T et al. Multivariate study of prognostic factors for differentiated thyroid carcinoma: the significance of histologic subtype. Int Surg 1993;78:10-15.
9. Cline RE, Shingleton WW. Long-term in the treatment of carcinoma of the thyroid. Am J Surg 1968;115:545-551.
10. Noguchi S, Noguchi A, Murakami N. Papillary carcinoma of the thyroid. II. Value of prophylactic lymph node excision. Cancer 1970;26:1061-1064.
11. Attie JN, Khafif RA, Steckler RM. Elective neck dissection in papillary carcinoma of the thyroid. Am J Surg 1971;122:464-471.
12. Noguchi M, Yagi H, Earashi M et al. Recurrence and mortality in patients with differentiated thyroid carcinoma. Int Surg 1995 (in press).
13. Krausz Y, Uziely B, Karger H et al. Recurrence-associated mortality in patients with differentiated thyroid carcinoma. J Surg Oncol 1993;52:164-168.
14. Russel WL, Ibanez ML, Clark RH, White EC. Thyroid carcinoma: Classification intraglandular dissemination, and clinicopathologic study based upon whole organ sections of 80 glands. Cancer 1963;16:1425-1460.
15. Buckwalter JA, Thomas CG Jr. Selection of surgical treatment for well-differentiated thyroid carcinomas. Ann Surg 1972;176:565-578.
16. Sakamoto A, Kasai N, Sugano H. Poorly differentiated carcinoma of the thyroid. A clinicopathologic entity for a high-risk group of papillary and follicular carcinomas. Cancer 1983;52:1849-1855.
17. Cady B, Rossi R, Silverman M, Wool M. Further evidence of the validity of risk group definition in differentiated thyroid carcinoma. Surgery 1985;6:1171-1178.
18. Donohue JH, Goldfien SD, Miller TR et al. Do the prognosis of papillary and follicular thyroid carcinoma differ? Am J Surg 1984;148:168-170.
19. Harada T, Shimaoka K, Yakumaru K et al. Prognosis of thyroid carcinoma. Int Adv Surg Oncol 1981;4:83-110.
20. Mizukami Y, Michigishi T, Nonomura A et al. Distant metastases indifferentiated thyroid carcinomas: A clinical and pathological study. Hum Pathol 1990;21:283-290.
21. Carcangui ML, Zampi G, Rosai J. Poorly differentiated "insular" thyroid carcinoma. A reinterpretation of Langhans' "wuchernde Struma" Am J Surg Pathol 1984;8:655-668.
22. Tscholl-Ducommun J, Hedinger CE. Papillary thyroid carcinomas. Morphology and prognosis. Virchows Arch (A) 1982;396:19-39.
23. Attie JN. Modified neck dissection in treatment of thyroid cancer: a safe procedure. Eur J Cancer Clin Oncol 1988;24:315-324.
24. Roka R, Niederle B, Fritsch A. Die transcervicale und transsternale Dissektion des Mediastinuums beim Carcinom der Schilddruese. Langenbecks Arch Chirur 1983;359:5-17.
25. Cunningham MP, Duda RB, Recant W et al. Survival discriminant for differentiated thyroid cancer. Am J Surg 1990;160:344-347.
26. Vickery AL Jr, Wang CA, Walker AM. Treatment of intrathyroidal papillary carcinoma of the thyroid. Cancer 1987;60:2587-2595.
27. Hoie J, Stenwig AE, Brennhovd IO. Surgery in papillary thyroid carcinoma; A review of 730 patients, J Surg Oncol 1988;37:147-151.
28. Iida F, Yonekura M, Miyakawa M. Study of intraglandular dissemination of thyroid cancer. Cancer 1969;24:764-771.
29. Clark OH. Total thyroidectomy. The treatment of choice for patients with differentiated thyroid cancer. Ann Surg 1982; 196: 361-370.
30. Harness JF, Fung L, Thompson NW et al. Total thyroidectomy: complications and technique. World J Surg 1986; 10:781-786.
31. Wanebo HJ, Andrews W, Kaiser DL. Thyroid cancer: Some basic considerations. Am J Surg 1981;142:474-479.
32. Harada T, Ito K, Shimaoka K et al. Fatal thyroid carcinoma, anaplastic transformation of adenocarcinoma. Cancer 1977; 39:2588-2596.
33. Heitz P, Moser H, Staub JJ. Thyroid cancer. A study of 573 thyroid tumors and 161 autopsy cases observed over a thirty-year period. Cancer 1976;37:2327-2337.
34. Vickery AL. Thyroid papillary carcinoma. Pathological and philosophical controversies. Am J Surg Pathol 1983;7:797-807.
35. Tollefsen HR, Shah JP, Huvos AG. Papillary carcinoma of the thyroid. Recurrence in the thyroid gland after initial surgical treatment. Am J Surg 1972;124:468-472.
36. Farrar WB, Cooperman M, James AG. Surgical management of papillary and follicular carcinoma of the thyroid. Ann Surg 1980;192:701-704.
37. Black BM, Ya Deau RW, Woolner LB. Surgical treatment of thyroidal carcinomas: A study of 885 cases observed in a 30-year period. Arch Surg 1964;88:610-618.
38. Baker RR, Hyland J. Papillary carcinoma of the thyroid gland. Surg Gynecol Obstet 1985;161:546-550.
39. Crile G, Antunez AR, Esselstyn CB Jr et al. The advantages of subtotal thyroidectomy and suppression of TSH in the primary treatment of papillary carcinoma of the thyroid. Cancer 1985;55: 2691-2697.
40. Schroder DM, Chambers A, France CJ. Operative strategy for thyroid cancer. Is total thyroidectomy worth the price? Cancer 1986;58:2320-2328.
41. Beahrs OH. Surgical treatment for thyroid cancer. Br J Surg 1984;71:976-979.
42. Mazzaferri RL. Papillary and follicular thyroid cancer: Selective therapy. Compr Ther 1981;7:6-14.
43. Rossi RL, Cady B, Silverman ML et al. Current results of conservative surgery for differentiated thyroid carcinoma. World J Surg 1986;10:612-622.
44. Cady B, Sedwick CE, Meissner WA et al. Changing clinical, pathologic, therapeutic, and survival patterns in differentiated thyroid carcinoma. Ann Surg 1976;184:541-543.
45. Bell RM. Thyroid carcinoma. Surg Clin North 1986;66:13-30.
46. Frazell EL, Foote FW jr. Papillary thyroid carcinoma: Pathological evidence of cervical node involvement. Cancer 1955;8:1164-1166.
47. Noguchi M, Tanaka S, Akiyama T et al. Clinicopathological studies of minimal thyroid and ordinary thyroid cancer. Jpn J Surg 1984;14:110-117.
48. Noguchi M, Yamada H, Ohta N et al. Regional lymph node metastases in well-differentiated thyroid carcinoma. Int Surg 1987; 72:100-103.
49. Ardito G, Cavallaro A, Mantovani M et al. Occult carcinoma of the thyroid, a changing pathology. J R Coll Surg Edinb 1982; 27:219-223.
50. Woolner LB, Lemmon ML, Beahrs PH et al. Occult papillary carcinoma of the thyroid: A study of 140 cases observed in a 30-year period. J Clin Endocrinol Metab 1960;20:89-105.
51. Coburn MC, Wanebo HJ. Prognostic factors and management considerations in patients with cervical metastases of thyroid cancer. Am J Surg 1992;164:671-676.
52. Ozaki O, Ito K, Kobayashi K et al. Modified neck dissection for patients with non-advanced differentiated carcinoma of the thyroid. World J Surg 1988;12:825-829.
53. Noguchi M, Kumaki T, Taniya T et al. Bilateral cervical lymph node metastases in well-differentiated thyroid cancer. Arch Surg 1990;125:804-806.
54. Block MA, Miller JM, Horn RC. Significance of mediastinal lymph node metastases in carcinoma of the thyroid. Am J Surg 1972;123:702-705.
55. Knishnamurphy GT, Blahd WH. Radioiodine therapy I-131 in the management of thyroid cancer. A prospective study. Cancer 1977;40:195-202.
56. Lee KY, Lore JM Jr. The treatment of metastatic thyroid disease. Otolaryngol Clin North Am 1990;23:475-493.
57. Frazell EL, Foote FW Jr. Papillary cancer of thyroid: a review of 25 years of experience. Cancer 1958;11:895-922.
58. McConahey WM, Hay ID, Woolner LB et al. Papillary thyroid cancer treated at the Mayo Clinic, 1946 through 1970: initial manifestation, pathologic findings, therapy, and outcome. Mayo Clin Proc 1986;61:978-996.
59. Carcangiu ML, Zampi G, Pupi A et al. Papillary carcinoma of the thyroid: a clinicopathologic study of 241 cases treated at the University of Florence, Italy. Cancer 1985;55:805-828.
60. Harwood J, Clark OH, Dunphy JE. Significance of lympn node metastases in differentiated thyroid cancer. Am J Surg 1978; 136:107-142.
61. Hamming JF, Van De Velde CJH, Fleuren GJ et al. Differentiated thyroid cancer; a stage-adapted approach to the treatment of regional lymph node metastases. Eur J Cancer Clin Oncol 1988; 24:325-330.
62. McGregor GI, Luoma A, Jackson SM. Lymph node metastases from well-differentiated thyroid cancer. A clinical review. Am J Surg 1985;149: 610-612.
63. Cady B. Surgery of thyroid cancer. World J Surg 1981;5:3-14.
64. Noguchi M, Kumaki T, Taniya T et al. Impact of neck dissection on survival in well-differentiated thyroid cancer: a multivariate analysis of 218 cases. Int Surg 1990;75;220-224.
65. Harness JK, Thompson NW, McLeod MK et al. Differentiated thyroid carcinoma in children and adolescents. World J Surg 1992;16:547-554.
66. Noguchi S, Murakami N. The value of lymph-node dissection in patients with differentiated thyroid cancer. Surg Clin North Am 1987;67:251-261.
67. Sellers M, Beenken S, Blankenship A et al. Prognostic significance of cervical lymph node metastases in differentiated thyroid cancer. Am J Surg 1992;164:578-581.
68. Thompson NW, Nishiyama RH, Harness JK. Thyroid carcinoma: current controversies. Curr Probl Surg 1978;15:1-67.
69. Scheumann GFW, Gimm O, Wegener G et al. Prognostic significance and surgical management of locoregional lymph node metastases in papillary thyroid cancer. World J Surg 1994;18:559-568.
70. Mazzaferri EL, Young RL. Papillary thyroid carcinoma: a 10-year follow-up report of the impact of therapy in 576 patients. Am J Med 1981;70:511-518.
71. DeGrout LJ, Kaplan EL, McCormick M et al. Natural history, treatment, and course of papillary thyroid carcinoma. J Clin Endocrinol Metab 1990;71:414-424.
72. Franssila KO. Prognosis in thyroid carcinoma. Cancer 1975;36: 1138-1146.
73. Noguchi S, Noguchi A, Murakami N. Papillary carcinoma of the thyroid. I. Developing pattern of metastases. Cancer 1970;26: 1053-1060.
74. McHenry CR, Rosen IB, Walfish PG. Prospective management of nodal metastases in differentiated thyroid cancer. Am J Surg 1991;162:353-356.
75. Simpson WJ, McKinney SE, Carruthers JS et al. Papillary and follicular thyroid cancer: Prognostic factors in 1578 patients. Am J Med 1987;83:479-488.
76. Massin JP, Savoie JC, Garnier H et al. Pulmonary metastases indifferentiated thyroid carcinoma. Study of 58 cases with implications for the primary tumor treatment. Cancer 1984;53:982-992.
77. Beierwaltes WH, Nishiyama RH, Thompson NW et al. Survival time and "cure" in papillary and follicular thyroid carcinoma with distant metastasis: Statistics following Uniyersity of Michigan therapy, J Nucl Med 1982;23:561-568.
78. Harness JK, Thompson NW, Sisson JC et al. Differentiated thyroid carcinomas. Treatment of distant metastasis. Arch Surg 1974;108:410-419.
79. Crile G Jr. Endocrine dependence of papillary carcinomas of the thyroid. JAMA 1966;195:721-724.
80. Beierwaltes WH. The treatment of thyroid carcinoma with radioactive iodine. Semin Nucl Med 1978;8:79-93.
81. Cady B, Rossi R. An expanded view of risk group definition indifferentiated thyroid carcinoma. Surgery 1988;104;947-953.
82. Hay ID, Grant OS, Taylor WF et al. Ipsilateral lobectomy versus bilateral lobar resection in papillary thyroid carcinoma: A retrospective analysis of surgical outcome using a novel prognostic scoring system. Surgery 1987;102:1088-1095.
83. 131I. JAMA 1970;214:1437-1442.
84. McHenry C, Jarosz H, Davis M et al. Selective postoperative radioactive iodine treatment of thyroid carcinoma. Surgery 1989;106:956-959.
85. Lennquist S. Surgical strategy in thyroid carcinoma: a clinical review Acta Chir Scand 1986;152:321-338.
86. Brennan MD, Bergstralh EJ, van Heerden JA et al. Follicular thyroid cancer treated at the Mayo Clinic, 1946 through 1970: Initial manifestations, pathologic findings, therapy, and outcome. Mayo Clin Proc 1991;66:11-22.
87. Jorda M, Gonzalez-Campora R, Mora J et al. Prognostic factors in follicular carcinoma of the thyroid. Arch Pathol Lab Med 1993; 117:631-635.
88. Kahn NF, Perzin- KH. Follicular carcinoma of the thyroid: an evaluation of the histologic criteria used for diagnosis. Pathol Annu 1983;18:221-253.
89. van Heerden JA, Hay ID, Goellner JR et al. Follicular thyroid carcinoma with capsular invasion alone: a non-threatening malignancy. Surgery 1992;112:1130-1138.
90. Lennquist S. The thyroid nodule. Diagnosis and surgical treatment. Surg Clin North Am 1987;67:213-232.
91. Mizukami Y, Michigishi T, Nonomura A et al. Thyroid carcinoma: Clinical, pathological correlations. Crit Rev Oncol Hematol 1995;18:67-102.